https://www.enterair.pl/slot-gacor/

ACUTE HEPATIC ENCEPHALOPATHY IN A FEMALE PATIENT WITH HEPATITIS E VIRUS WITH A FAVOURABLE TREATMENT OUTCOME: A CASE REPORT

  • O. N. Domashenko State Educational Institution of Higher Professional Education «M.Gorki Donetsk National Medical University», Donetsk, Ukraine
  • S. G. Tiumentseva State Educational Institution of Higher Professional Education «M.Gorki Donetsk National Medical University», Donetsk, Ukraine
  • А. N. Kolesnikov State Educational Institution of Higher Professional Education «M.Gorki Donetsk National Medical University», Donetsk, Ukraine
  • M. N. Snegina Donetsk Clinical Territorial Medical Association, Donetsk, Ukraine
  • A. V. Bilichenko Donetsk Clinical Territorial Medical Association, Donetsk, Ukraine
Keywords: Hepatitis E virus, hepatic encephalopathy, treatment

Abstract

The article covers the case of HEV with clearly marked clinical manifestations in a 25-year-old non pregnant woman resident in non-endemic region without bad habits and chronic somatic diseases. The case has been confirmed by the detection of IgM and IgG antibodies against HEV. Viral hepatitises А, В, С, D, G have been ruled out by laboratory test results (АТ–IgM HAV, HBsAg, AT–IgM HBcAg, DNA HBV, AT HCV cumulative, RNA HCV, RNA HDV, RNA HGV are not detected), as well as Wilson’s disease, toxic and autoimmune hepatitises. On the 35th day, severe progression of the disease was aggravated by hepatic encephalopathy grade IV. This patient’s combination therapy is characterized by absence of glucocorticosteroids in the course of treatment and by four plasmapheresis treatment sessions that were effective despite marked coagulopathy.

References


1. Malinnikova EY, Kuregyan KK, Polyakov AD, Amon EP, Mikhailov MI. Virusnyj gepatit E. Sovremennyj vzgljad na problemu [Viral hepatitis E. A modern view of the problem]. Medicina jekstremalnyh situacij [Medicine of Extreme Situations]. 2018;20(3):293-299. (Russian).


2. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988-997. doi: 10.1002/hep.25505.


3. European Centre for Disease Prevention and Control. Hepatitis E in the EU/EEA, 2005-2015. Baseline assessment of testing, diagnosis, surveillance and epidemiology. Stockholm: ECDC; 2017. 29 p.


4. Pischke S, Behrendt P, Bock CT, Jilg W, Manns MP, Wedemeyer H. Hepatitis E in Germany – an under-reported infectious disease. Dtsch. Arztebl. Int. 2014;111(35-36):577-583. doi: 10.3238/arztebl.2014.0577.


5. Kovalevskaya EV, Kalinina TN, Gilmutdinov RG, Causeway NA. K voprosu o neobhodimosti izuchenija virusnogo gepatita E v nejendemichnom regione na primere Orenburgskoj oblasti [On the need for the study of viral hepatitis E in nonaendemic region by the example Orenburg region].Vestnik Orenburgskogo gosudarstvennogo universiteta. 2012;10(146):49-53. (Russian).


6. Zhavoronok SV, Dotsenko ML, Rakovich SV, Sarapina EP, Anisko LA. Virusnyj gepatit E: sovremennoe sostojanie problemy [Viral hepatitis E: current state of the problem]. Gepatologija i Gastrojenterologija [Hepatology and Gastroenterology]. 2018;2(1):14-20. (Russian).


7. Semenov VM, Lyatos IA. Rasprostranennost virusnogo gepatita E v voinskih kollektivah [Prevalence of the viral hepatitis E in military collectives]. Voennaja medicina. 2017;2(43):75-76. (Russian).


8. Malyj VP, Shepileva NV, Brjadko NV, Tarasenko SM. Virusnyj gepatit E v Ukraine. Klinichna imunologija. Alergologija. Infektologija [Klinichna immunolohiia. Alerholohiia. Infektolohiia]. 2015;7(86):5-8. (Russian).


9. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic viral hepatitis in pregnancy. J. Viral Hepat. 2003;10(1):61-69.


10. Mamun-Al-Mahtab, Rahman S, Khan M, Karim F. HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh. J. Health Popul. Nutr. 2009;27(1):14-19.


11. Zha M, Li F, Xu W, Chen B, Sun Z. Isolation and characterization of islet stellate cells in rat. Islets. 2014;6(2):e28701. doi: 10.4161/isl.28701.


12. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008;28(9):1190-1199. doi: 10.1111/j.1478-3231.2008.01840.x.


13. World Health Organization. Beyond the scope of the report: hepatitis A, D and E. Epidemiological update: increasing mortality calls for action.


14. Global hepatitis report, 2017. France: WHO Press; 2017. p. 5-21.


15. Fogeda M, de Ory F, Avellón A, Echevarría JM. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J. Clin. Virol. 2009;45(3):259-261.


16. Ylchenko LJu, Malynnykova EJu. Fulminantnye sluchai gepatita E. Sovremennye problemy nauki i obrazovanija [Internet]. 2014;2. Available from: https://www.science-education. ru/ru/article/view?id=12501. (Russian).

Published
2019-06-06
How to Cite
1.
Domashenko ON, Tiumentseva SG, KolesnikovАN, Snegina MN, Bilichenko AV. ACUTE HEPATIC ENCEPHALOPATHY IN A FEMALE PATIENT WITH HEPATITIS E VIRUS WITH A FAVOURABLE TREATMENT OUTCOME: A CASE REPORT. journalHandG [Internet]. 2019Jun.6 [cited 2024Nov.21];3(1):99-102. Available from: http://hepatogastro.grsmu.by/index.php/journalHandG/article/view/106
https://stok.bte.co.id/pg/ https://coverage.bte.co.id/public/play/ https://lapor.bte.co.id/rungkat/ https://itj.jakartamrt.co.id/data/ https://dev.idcomm.id/wp-includes/IXR/slot-gacor/